LRTM2 anticorps (AA 36-310)

N° du produit ABIN7158062

Détail du produit anti-LRTM2 anticorps

Antigène: LRTM2 (Leucine-Rich Repeats and Transmembrane Domains 2 (LRTM2))

Épitope: AA 36-310

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LRTM2 est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (IHC), ELISA

Réactivité croisée: Humain, Rat

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Leucine-rich repeat and transmembrane domain-containing protein 2 protein (36-310AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200, IF:1:50-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur LRTM2

Antigène: LRTM2 (Leucine-Rich Repeats and Transmembrane Domains 2 (LRTM2))

Autre désignation: LRTM2 (LRTM2 Produits)

Synonymes: anticorps A230084J22, anticorps AI841794, anticorps leucine rich repeats and transmembrane domains 2, anticorps leucine-rich repeats and transmembrane domains 2, anticorps LRTM2, anticorps Lrtm2

Sujet:

Background: cytoplasm, protein kinase inhibitor activity, cytokine-mediated signaling pathway, negative regulation of JAK-STAT cascade, negative regulation of protein kinase activity.

Aliases: Leucine-rich repeat and transmembrane domain-containing protein 2 antibody, Leucine-rich repeats and transmembrane domains 2 antibody, Lrtm2 antibody, LRTM2_HUMAN antibody

UniProt: Q8N967